Saturday, December 02, 2006

News

Ranbaxy buys S African generic co
Ranbaxy Laboratories has acquired South Africa’s fifth-largest generic company Be-Tabs Pharmaceuticals for $70 million. This acquisition will more than double Ranbaxy’s South Africa’s sales to $55 million and provide the Indian pharma company with an access to manufacturing facility in that country.

According to sources, Dr Reddy’s Laboratories, too, was in the race for Be-Tabs, but Ranbaxy was successful in clinching the deal. The acquisition will be EPS accretive, and is valued at 2.2 times of sales and 7.7 times of EBITDA multiples.
To Read MoreClick Here

Dabur set to spice up food business
Dabur is scripting a strategy to give a better play to the food business in its portfolio. Its wholly owned subsidiary — Dabur Foods — is planning an entry into the ready-to-eat packaged foods market under the brand, Hommade.
To Read MoreClick Here

Thomas Cook acquires Travel Corp for Rs 182.5 cr
Travel and forex major Thomas Cook India (TCIL) on Friday announced two acqusitions in the travel and visa services space. The company will buy out 100% of Mumbai-based travel company Travel Corp of India (TCI) in an all-cash transaction worth Rs 182.5 crore.
To Read MoreClick Here

0 Comments:

Post a Comment

<< Home